Minorities?both racial and ethnic?continue to lack recognition that cardiovascular disease (CVD) is the No.1 reason for death in women, even though overall understanding of the disease's rank among death causes has doubled in the last 13 years, a new study shows.
Minorities-both racial and ethnic-still are unaware that cardiovascular disease (CVD) is the leading cause of death in women, although overall understanding of the disease’s rank among causes of death has doubled in the last 13 years, a new study from Columbia University Medical Center in New York shows. The study attributes this lack of awareness to numerous misperceptions on the part of the women and to obstacles to CVD prevention.
The standardized study, published in the online edition of Circulation, measured the level of understanding of heart disease risk among 2,300 women aged 25 years and older, as well as the roadblocks to preventing the occurrence of CVD. Trends were assessed using triennial surveys dating to 1997.
Participants polled via telephone were significantly more aware of CVD risk in 2009 than in 1997 (54% vs 30%; P.0001); likewise, they were significantly more aware that CVD was the leading cause of death in women (P≤.0001). Much less informed as to the risk of the disease were black and Hispanic women compared with white women, although the gap is narrowing.
The majority of women cited therapies for CVD prevention that are not evidence based. Reasons precluding CVD prevention included family and caretaker tasks (51%) and lack of clarity in the media (42%). Overall, 91% of women believed that access to healthy foods, recreation (80%), and nutrition data offered in restaurants (79%) would improve CVD prevention within the community.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More